before and after semaglutide weight loss (Ozempic® & Wegovy®) Results: Timelines (2026) My Epic Semaglutide Taper Journey!

This finding not only supports the clinical relevance of continuous BUN monitoring but also suggests that timely surveillance and management of renal function and volume status may offer a therapeutic window for improving outcomes

then again, most say the results were worth it

"Tirzepatide versus Insulin Glargine in Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4): A Randomised, Open-Label, Parallel-Group, Multicentre, Phase 3 Trial." The Lancet, 2021, 398(10313), 1811-1824

When Dual-Compound Therapy Outperforms Single Agents For patients experiencing semaglutide non-response, tirzepatide represents a mechanistically distinct option

Call 858-295-4001 with questions